Preparation and Crystallization of the Grb7 SH2 Domain in Complex with the G7-18NATE Nonphosphorylated Cyclic Inhibitor Peptide

Overview

Journal Acta Crystallogr Sect F Struct Biol Cryst Commun

Date 2010 Dec 9

PMID 21139214

Authors

Min Y Yap

Matthew C J Wilce

Daniel J Clayton

Patrick Perlmutter

Marie-Isabel Aguilar

Jacqueline A Wilce

Affiliations

Soon will be listed here.

Abstract

Grb7 is an adapter protein that is involved in signalling pathways that mediate eukaryotic cell proliferation and migration. Its overexpression in several cancer types has implicated it in cancer progression and led to the development of the G7-18NATE cyclic peptide inhibitor. Here, the preparation of crystals of G7-18NATE in complex with its Grb7 SH2 domain target is reported. Crystals of the complex were grown by the hanging-drop vapour-diffusion method using PEG 3350 as the precipitant at room temperature. X-ray diffraction data were collected from crystals to 2.4 Å resolution using synchrotron X-ray radiation at 100 K. The diffraction was consistent with space group P2(1), with unit-cell parameters a=52.7, b=79.1, c=54.7 Å, α=γ=90.0, β=104.4°. The structure of the G7-18NATE peptide in complex with its target will facilitate the rational development of Grb7-targeted cancer therapeutics.

References

Han D, Shen T, Guan J . Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration. J Biol Chem. 2000; 275(37):28911-7. DOI: 10.1074/jbc.M001997200. View

Pero S, Shukla G, Cookson M, Flemer Jr S, Krag D . Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells. Br J Cancer. 2007; 96(10):1520-5. PMC: 2359946. DOI: 10.1038/sj.bjc.6603732. View

Stein D, Wu J, Fuqua S, Roonprapunt C, Yajnik V, DEustachio P . The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J. 1994; 13(6):1331-40. PMC: 394949. DOI: 10.1002/j.1460-2075.1994.tb06386.x. View

Han D, Shen T, Guan J . The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene. 2001; 20(44):6315-21. DOI: 10.1038/sj.onc.1204775. View

Leslie A . Integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr. 1999; 55(Pt 10):1696-702. DOI: 10.1107/s090744499900846x. View

Pero S, Oligino L, Daly R, Soden A, Liu C, Roller P . Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7. J Biol Chem. 2002; 277(14):11918-26. DOI: 10.1074/jbc.M111816200. View

Kishi T, Sasaki H, Akiyama N, Ishizuka T, Sakamoto H, Aizawa S . Molecular cloning of human GRB-7 co-amplified with CAB1 and c-ERBB-2 in primary gastric cancer. Biochem Biophys Res Commun. 1997; 232(1):5-9. DOI: 10.1006/bbrc.1997.6218. View

Shen T, Guan J . Grb7 in intracellular signaling and its role in cell regulation. Front Biosci. 2004; 9:192-200. DOI: 10.2741/1229. View

Ivancic M, Daly R, Lyons B . Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2. J Biomol NMR. 2003; 27(3):205-19. DOI: 10.1023/a:1025498409113. View

10.

Han D, Guan J . Association of focal adhesion kinase with Grb7 and its role in cell migration. J Biol Chem. 1999; 274(34):24425-30. DOI: 10.1074/jbc.274.34.24425. View

11.

Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands J . Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer Res. 1997; 57(1):28-31. View

12.

Bradshaw J, Waksman G . Molecular recognition by SH2 domains. Adv Protein Chem. 2002; 61:161-210. DOI: 10.1016/s0065-3233(02)61005-8. View

13.

Tanaka S, Pero S, Taguchi K, Shimada M, Mori M, Krag D . Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. J Natl Cancer Inst. 2006; 98(7):491-8. DOI: 10.1093/jnci/djj105. View

14.

Janes P, Lackmann M, Church W, Sanderson G, Sutherland R, Daly R . Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7. J Biol Chem. 1997; 272(13):8490-7. DOI: 10.1074/jbc.272.13.8490. View

15.

Porter C, Wilce J . NMR analysis of G7-18NATE, a nonphosphorylated cyclic peptide inhibitor of the Grb7 adapter protein. Biopolymers. 2007; 88(2):174-81. DOI: 10.1002/bip.20667. View

16.

Songyang Z, Shoelson S, Chaudhuri M, Gish G, Pawson T, Haser W . SH2 domains recognize specific phosphopeptide sequences. Cell. 1993; 72(5):767-78. DOI: 10.1016/0092-8674(93)90404-e. View

17.

Porter C, Matthews J, Mackay J, Pursglove S, Schmidberger J, Leedman P . Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation. BMC Struct Biol. 2007; 7:58. PMC: 2131756. DOI: 10.1186/1472-6807-7-58. View

18.

McCoy A, Grosse-Kunstleve R, Adams P, Winn M, Storoni L, Read R . Phaser crystallographic software. J Appl Crystallogr. 2009; 40(Pt 4):658-674. PMC: 2483472. DOI: 10.1107/S0021889807021206. View

19.

Waksman G, Kominos D, Robertson S, Pant N, Baltimore D, Birge R . Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature. 1992; 358(6388):646-53. DOI: 10.1038/358646a0. View